|
Volumn 106, Issue 8, 2005, Pages 2921-2922
|
Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
ENOXAPARIN;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
HUMAN;
KNEE ARTHROPLASTY;
LETTER;
MAJOR CLINICAL STUDY;
ORTHOPEDIC SURGERY;
PRIORITY JOURNAL;
SEROLOGY;
STATISTICAL SIGNIFICANCE;
THROMBOCYTE ACTIVATION;
THROMBOCYTOPENIA;
THROMBOSIS;
TOTAL HIP PROSTHESIS;
|
EID: 27144489083
PISSN: 00064971
EISSN: 00064971
Source Type: Journal
DOI: 10.1182/blood-2005-05-1824 Document Type: Letter |
Times cited : (92)
|
References (6)
|